S2900 Robotic Surgery - Cloud RCM Solutions

Robotic-assisted surgery can expand a general surgery group’s procedural capabilities, but the technology itself does not automatically create additional professional reimbursement.

That creates an important financial question for practice owners:

Where is revenue being lost between the robotic procedure, the claim, and the final payment?

The economics can be difficult to balance. Recent industry analysis has placed the acquisition cost of a major robotic surgical platform in the $1.5 million to $2.5 million range, with maintenance, instruments, training, and other ongoing expenses adding to the cost of a robotic program. These figures vary by platform, contract, facility, and utilization, so they should be treated as program-level estimates rather than a universal cost.

At the same time, professional reimbursement generally remains tied to the underlying surgical procedure, payer contract, coding, documentation, and payment rules.

The American College of Surgeons highlighted the complexity of robotic surgery economics in 2026. Using Intuitive’s 2024 figures of 1.7 million operations and $5.6 billion in revenue, ACS calculated an average of approximately $3,300 per operation. ACS also cautioned that this is not a universal cost for every robotic case and that procedure mix affects the economics.

For general surgery groups, the more actionable question is not simply whether robotic surgery is expensive.

It is whether your revenue cycle is capturing everything the documentation and payer contract support.

Does Robotic Surgery Pay More?

Not automatically.

The underlying CPT code generally describes the surgical service being performed. Using a robotic platform does not, by itself, mean the surgeon should report a different primary procedure code or expect a separate professional payment.

This creates a financial gap that practice owners need to understand.

A robotic program may involve:

  • $1.5M–$2.5M in reported system acquisition costs
  • $100,000+ annually in maintenance and related program expenses in some published estimates
  • Additional disposable robotic instruments
  • Operating-room resources
  • Staff training
  • Surgeon training and learning-curve costs
  • Potentially longer procedure times for certain cases

Yet the professional claim may still be reimbursed according to the underlying surgical procedure and applicable payer methodology.

Higher technology cost does not automatically equal higher physician reimbursement.

That is why robotic surgery billing should be evaluated as an RCM issue as well as a clinical and operational investment.

1. S2900 Does Not Automatically Create Additional Revenue

One of the most common questions in robotic surgery billing is whether the robotic assistance itself can be billed separately.

Practices should not assume that reporting HCPCS S2900 creates an additional professional payment.

S2900 is associated with robotic surgical assistance, but its reporting and payment treatment can vary by payer. Practices should verify the applicable payer policy instead of treating S2900 as an automatic revenue line.

The primary billing principle remains:

Code the actual surgical procedure performed and follow the payer’s specific rules for robotic assistance and related reporting.

Before assuming that a robotic case should generate additional reimbursement, your billing team should review:

  1. Primary CPT selection
  2. Payer-specific policy
  3. Contracted fee schedule
  4. NCCI and other coding edits
  5. Historical claim results
  6. Actual payment against expected reimbursement

This prevents the robotic platform from becoming the focus when the actual problem is coding or payment variance.

2. Modifier 22 Is Not a “Robotic Surgery” Modifier

Another potential revenue leakage point is Modifier 22, Increased Procedural Services.

Robotic assistance alone does not establish the need for Modifier 22.

Modifier 22 should be supported by documentation showing that the procedure required substantially greater work than normally required for the reported service.

Possible circumstances may include:

  • Extensive adhesions
  • Unexpected anatomy
  • Significant additional dissection
  • Unusual technical difficulty
  • Additional operative work
  • Other documented circumstances that materially increase physician work

The operative note should explain what made the procedure substantially more difficult and why the additional work exceeded the usual service.

Simply documenting “robotic-assisted surgery” does not automatically establish Modifier 22.

3. Modifier 22 Claims Need More Than a Modifier

There is useful evidence showing why practices should monitor Modifier 22 closely.

A JAMA Surgery study analyzed 625,316 fee-for-service Medicare surgical procedures involving 10 common operations in 2021.

Among the claims studied, those submitted with Modifier 22 had a 7.4% denial rate, compared with 4.0% for claims without Modifier 22.

That is a difference of 3.4 percentage points, or roughly 85% higher relative to the 4.0% comparison rate.

Importantly, the study was not specific to robotic surgery. Therefore, these numbers should not be presented as robotic-surgery denial rates.

The financial lesson for a general surgery group is still important:

If your practice uses Modifier 22, measure whether the additional reimbursement actually survives payer adjudication.

Track:

  • Modifier 22 submission rate
  • Modifier 22 denial rate
  • Appeals submitted
  • Appeals overturned
  • Additional reimbursement received
  • Payer-specific outcomes

A modifier that is consistently submitted but frequently denied may indicate a documentation, coding, payer-policy, or appeal-process problem.

Similar coding and reimbursement issues also affect plastic surgery billing, particularly for procedure-specific services and documentation.

4. NCCI Edits Can Create Another Revenue Leakage Point

Robotic surgery does not create an exception to standard coding rules.

CMS’s 2026 Medicare NCCI Policy Manual became effective January 1, 2026. CMS uses NCCI policies to promote correct coding and reduce inappropriate payment.

NCCI includes several important edit types relevant to surgical billing:

  • Procedure-to-procedure edits
  • Medically unlikely edits
  • Add-on code requirements
  • Modifier-related rules
  • Unit limitations
  • Bundled services

CMS also updates NCCI files quarterly.

For a general surgery practice performing high-value procedures, that means a coding workflow based on outdated edits can create avoidable claim problems.

The robotic platform does not change the need for correct CPT reporting, modifier use, or payer-specific coding review.

5. A Paid Claim Can Still Be Underpaid

Not every revenue problem appears as a denial.

A claim can be:

Submitted → Accepted → Adjudicated → Paid

and still produce less reimbursement than expected.

For robotic general surgery cases, your RCM team should compare:

Expected allowed amount vs. actual payer payment.

Track this by:

  • CPT code
  • Payer
  • Plan
  • Surgeon
  • Procedure
  • Modifier
  • Place of service

This can expose recurring underpayments that never appear on a standard denial report.

For example, if a payer repeatedly pays below the contracted amount for a high-volume surgical CPT, the problem is not claim submission. It is payment variance and contract compliance.

6. The Robot May Be Expensive. Your RCM Should Not Add to the Cost.

The financial pressure of robotic surgery is not limited to the purchase price.

Published financial analyses have identified several cost drivers, including equipment, maintenance, disposable instruments, training, operating-room time, and procedure duration.

A 2026 FutureBridge analysis also emphasized that the economics of robotic surgery can vary considerably by procedure and that downstream benefits such as shorter hospital stays or fewer complications do not necessarily accrue to the same party carrying the technology cost.

For a physician group, this distinction matters.

Your practice may carry the professional-side RCM burden while other parts of the healthcare system experience different financial effects from the procedure.

That makes accurate reimbursement tracking essential.

RCM cannot eliminate the cost of the robot.

It can help identify avoidable revenue leakage from:

  • Incorrect CPT selection
  • Unsupported Modifier 22 reporting
  • NCCI-related claim issues
  • Denials
  • Underpayments
  • Incorrect contractual adjustments
  • A/R delays
  • Missed appeal opportunities

7. Operating-Room Efficiency Still Matters

Robotic surgery economics cannot be evaluated from reimbursement alone. The American College of Surgeons notes that robotic surgery involves additional costs compared with other minimally invasive approaches and that the overall equation depends on factors such as procedure type, utilization, equipment, consumables, and reimbursement.

A robotic program may involve equipment, instruments, training, operating-room resources, and procedure-related costs. These considerations are also important when evaluating an ASC billing strategy

That means practice owners should monitor both clinical/operational performance and RCM performance.

Important measures include:

MetricWhat it tells you
Robotic cases by CPTWhich procedures generate volume
Average allowed amountExpected reimbursement
Actual paymentCollected revenue
Payment variancePotential underpayments
Denial rateClaim-level leakage
Modifier 22 rateIncreased-service reporting
Modifier 22 recoveryFinancial result of those claims
Days in A/RCollection speed
Average OR timeOperational efficiency
Payer mixReimbursement exposure
Case volumeProgram utilization

8. Don’t Forget the Global Surgical Period

The financial analysis should continue after the primary claim is paid.

For Medicare, most surgical procedures have a 10-day or 90-day global period, depending on the procedure. CMS’s global surgery framework includes postoperative services within the applicable global period.

For general surgery groups, this means robotic cases should not be analyzed only by looking at the initial surgical claim.

Review:

  • Postoperative visits
  • Global-period documentation
  • Appropriate modifiers
  • Transfer-of-care situations
  • Separately reportable services
  • Postoperative claim activity

A high-value surgical case can create revenue-cycle issues weeks after the operating-room service.

How Much Revenue Is Your Robotic Program Actually Capturing?

A useful robotic surgery RCM review should connect the procedure to the final payment.

For each major robotic procedure, ask:

What CPT was billed?

What was the contracted allowed amount?

What did the payer actually pay?

Was anything denied or bundled?

Was Modifier 22 reported?

If Modifier 22 was reported, was it supported and paid?

How long did the claim remain in A/R?

Was the contractual adjustment correct?

These questions turn robotic surgery from a general technology discussion into a measurable revenue-cycle analysis.

Robotic Surgery RCM Audit Checklist

Before evaluating the financial performance of your robotic surgery program, review:

Coding

  • Are the correct primary CPT codes being reported?
  • Are robotic procedures being coded according to the actual operation?
  • Are modifiers supported by documentation?
  • Are current NCCI edits incorporated into the workflow?

Documentation

  • Does the operative report support the services billed?
  • Does it clearly document additional work when Modifier 22 is reported?
  • Are unusual circumstances described in sufficient detail?

Reimbursement

  • What is the contracted allowed amount?
  • What was actually paid?
  • Which payers show recurring payment variances?
  • Are contractual adjustments accurate?

Denials and A/R

  • Which robotic CPTs generate the most denials?
  • What are the primary denial reasons?
  • How much revenue is recovered through appeals?
  • How long do high-dollar robotic claims remain outstanding?

Find the Gap Between Expected and Actual Revenue

Robotic surgery can create a gap between procedure costs and reimbursement. Coding errors, denials, underpayments, NCCI issues, and A/R delays can add to that gap.

How much should each robotic case pay, and how much are you actually collecting?

Let CloudRCM Solutions help identify potential revenue leakage in your surgical billing.

Schedule an Appointment to review your robotic surgery RCM performance.

Let’s Get Started